Literature DB >> 28212759

Psoriasis and comorbid diseases: Epidemiology.

Junko Takeshita1, Sungat Grewal2, Sinéad M Langan3, Nehal N Mehta4, Alexis Ogdie5, Abby S Van Voorhees6, Joel M Gelfand7.   

Abstract

Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known comorbidity of psoriasis. A rapidly expanding body of literature in various populations and settings supports additional associations between psoriasis and cardiometabolic diseases, gastrointestinal diseases, kidney disease, malignancy, infection, and mood disorders. The pathogenesis of comorbid disease in patients with psoriasis remains unknown; however, shared inflammatory pathways, cellular mediators, genetic susceptibility, and common risk factors are hypothesized to be contributing elements. As additional psoriasis comorbidities continue to emerge, education of health care providers is essential to ensuring comprehensive medical care for patients with psoriasis.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  Crohn's disease; cardiovascular disease; chronic kidney disease; comorbidities; depression; infection; lymphoma; metabolic syndrome; nonalcoholic fatty liver disease; psoriasis; psoriatic arthritis

Mesh：

Year:  2017        PMID： 28212759      PMCID： PMC5731650          DOI： 10.1016/j.jaad.2016.07.064

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  155 in total

1.  Psoriasis and arthritis. Clinicopathologic study.

Authors:  W B REED; S W BECKER; R ROHDE; C L HEISKELL
Journal:  Arch Dermatol       Date:  1961-04

2.  Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus.

Authors:  Noemí Eirís; Leire González-Lara; Jorge Santos-Juanes; Rubén Queiro; Eliecer Coto; Pablo Coto-Segura
Journal:  J Dermatol Sci       Date:  2014-06-11       Impact factor: 4.563

Review 3.  Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.

Authors:  Axel Patrice Villani; Marie Rouzaud; Morgane Sevrain; Thomas Barnetche; Carle Paul; Marie-Aleth Richard; Marie Beylot-Barry; Laurent Misery; Pascal Joly; Michel Le Maitre; Selim Aractingi; François Aubin; Alain Cantagrel; Jean-Paul Ortonne; Denis Jullien
Journal:  J Am Acad Dermatol       Date:  2015-06-06       Impact factor: 11.527

4.  Medical comorbidity associated with psoriasis in adults: a population-based study.

Authors:  Y-W Yang; J J Keller; H-C Lin
Journal:  Br J Dermatol       Date:  2011-09-29       Impact factor: 9.302

5.  Attributable risk estimate of severe psoriasis on major cardiovascular events.

Authors:  Nehal N Mehta; YiDing Yu; Rebecca Pinnelas; Parasuram Krishnamoorthy; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

6.  Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study.

Authors:  Emmilia A Dowlatshahi; Maryam Kavousi; Tamar Nijsten; M Arfan Ikram; Albert Hofman; Oscar H Franco; Marlies Wakkee
Journal:  J Invest Dermatol       Date:  2013-03-14       Impact factor: 8.551

7.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

Review 8.  Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  J Am Acad Dermatol       Date:  2013-01-27       Impact factor: 11.527

9.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

10.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus.

Authors:  E Y M G Fung; D J Smyth; J M M Howson; J D Cooper; N M Walker; H Stevens; L S Wicker; J A Todd
Journal:  Genes Immun       Date:  2008-12-25       Impact factor: 2.676
View more
  186 in total

1.  Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.

Authors:  Tom C Chan; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2018-03-19       Impact factor: 5.091

Review 2.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

Review 3.  Research Techniques Made Simple: Murine Models of Human Psoriasis.

Authors:  Jason E Hawkes; Jonas A Adalsteinsson; Johann E Gudjonsson; Nicole L Ward
Journal:  J Invest Dermatol       Date:  2018-01       Impact factor: 8.551

4.  Response to ixekizumab in a patient of psoriasis with secondary failure to secukinumab.

Authors:  Saurabh Mittal
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

5.  Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Authors:  Marilyn T Wan; Daniel B Shin; Rebecca A Hubbard; Megan H Noe; Nehal N Mehta; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-11-08       Impact factor: 11.527

Review 6.  Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.

Authors:  Caleb Jeon; Sahil Sekhon; Di Yan; Ladan Afifi; Mio Nakamura; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

7.  Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.

Authors:  Wei Wang; Gao-Feng Shu; Kong-Jun Lu; Xiao-Ling Xu; Min-Cheng Sun; Jing Qi; Qiao-Ling Huang; Wei-Qiang Tan; Yong-Zhong Du
Journal:  J Nanobiotechnology       Date:  2020-05-24       Impact factor: 10.435

8.  Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.

Authors:  F D'Amico; M Granata; E Skarmoutsou; C Trovato; G Lovero; P Gangemi; V Longo; M Pettinato; M C Mazzarino
Journal:  Inflamm Res       Date:  2018-03-31       Impact factor: 4.575

Review 9.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

10.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.